Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 1999

View Archived Issues

Eisai product pipeline update

Milestone achieved in Warner-Lambert/Unigene collaboration for oral calcitonin product

ID Biomedical seeks U.S. marketing clearance for MRSA test

SomatoKine reduces insulin use, improves glycemic control in type I diabetes

Access to acquire Virologix

FDA issues complete response letter for Rebif BLA

Endorex updates cancer and drug delivery programs

Novel hypoglycemic compounds designed at RPR

Novel vitamin D compounds with favorable biological profile from WARF

Pfizer discloses novel macrolide antibiotics

PDE4 inhibitors claimed by Byk Gulden for airways disorders

Vitronectin receptor antagonists with a benzocycloheptene core designed at SB

Second Ligand/Wyeth-Ayerst SERM to enter clinical trials shortly

Janssen confirms lubeluzole no longer under development

SS Pharm. outlicenses drug candidates to speed development, reduce costs

Alertec approved in Canada for treatment of narcolepsy

Biochemical and pharmacological profile of new MAO-A inhibitor: 2614W94

Cubist Pharmaceuticals initiates pivotal clinical trials for daptomycin

Licensing opportunity from BTG: xanthine oxidase inhibitors for treatment of ARDS

Epothilone analogue markedly suppresses growth of or cures MDR tumors in vivo

RCT supports early-stage life science discoveries originating in New England

Vasoflux is superior to other anticoagulants due to its unique mechanism of action

HFA-134a-BDP controls asthma at half the dose of traditional inhalers

Gadophrin-2 in the assessment of infarct size in dogs

Preclinical results obtained with candidate antidiabetic support further testing

Nuvance advances to phase II clinical trials for long-term control of asthma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...